118 related articles for article (PubMed ID: 22160776)
1. Activation of renal angiotensin type 1 receptor contributes to the pathogenesis of progressive renal injury in a rat model of chronic cardiorenal syndrome.
Homma T; Sonoda H; Manabe K; Arai K; Mizuno M; Sada T; Ikeda M
Am J Physiol Renal Physiol; 2012 Mar; 302(6):F750-61. PubMed ID: 22160776
[TBL] [Abstract][Full Text] [Related]
2. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
[TBL] [Abstract][Full Text] [Related]
3. Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats.
Dejima T; Tamura K; Wakui H; Maeda A; Ohsawa M; Kanaoka T; Haku S; Kengo A; Masuda S; Shigenaga A; Azuma K; Matsuda M; Yabana M; Hirose T; Uchino K; Kimura K; Nagashima Y; Umemura S
J Hypertens; 2011 Oct; 29(10):1919-29. PubMed ID: 21844822
[TBL] [Abstract][Full Text] [Related]
4. Low-protein diet supplemented with ketoacids ameliorates proteinuria in 3/4 nephrectomised rats by directly inhibiting the intrarenal renin-angiotensin system.
Zhang JY; Yin Y; Ni L; Long Q; You L; Zhang Q; Lin SY; Chen J
Br J Nutr; 2016 Nov; 116(9):1491-1501. PubMed ID: 27753426
[TBL] [Abstract][Full Text] [Related]
5. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
Vaziri ND; Bai Y; Ni Z; Quiroz Y; Pandian R; Rodriguez-Iturbe B
J Pharmacol Exp Ther; 2007 Oct; 323(1):85-93. PubMed ID: 17636006
[TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid receptor activation: a major contributor to salt-induced renal injury and hypertension in young rats.
Kawarazaki H; Ando K; Fujita M; Matsui H; Nagae A; Muraoka K; Kawarasaki C; Fujita T
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1402-9. PubMed ID: 21478481
[TBL] [Abstract][Full Text] [Related]
7. Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory.
Gonçalves AR; Fujihara CK; Mattar AL; Malheiros DM; Noronha Ide L; de Nucci G; Zatz R
Am J Physiol Renal Physiol; 2004 May; 286(5):F945-54. PubMed ID: 15075190
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models.
Kusumoto K; Igata H; Ojima M; Tsuboi A; Imanishi M; Yamaguchi F; Sakamoto H; Kuroita T; Kawaguchi N; Nishigaki N; Nagaya H
Eur J Pharmacol; 2011 Nov; 669(1-3):84-93. PubMed ID: 21816148
[TBL] [Abstract][Full Text] [Related]
9. The effect of spironolactone on cardiac and renal fibrosis following myocardial infarction in established hypertension in the transgenic Cyp1a1Ren2 rat.
Leader CJ; Wilkins GT; Walker RJ
PLoS One; 2021; 16(11):e0260554. PubMed ID: 34843581
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
Whaley-Connell AT; Chowdhury NA; Hayden MR; Stump CS; Habibi J; Wiedmeyer CE; Gallagher PE; Tallant EA; Cooper SA; Link CD; Ferrario C; Sowers JR
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1308-14. PubMed ID: 16788142
[TBL] [Abstract][Full Text] [Related]
11. Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats.
Vaněčková I; Kujal P; Husková Z; Vaňourková Z; Vernerová Z; Certíková Chábová V; Skaroupková P; Kramer HJ; Tesař V; Červenka L
Kidney Blood Press Res; 2012; 35(5):382-92. PubMed ID: 22487948
[TBL] [Abstract][Full Text] [Related]
12. An angiotensin II type-I receptor blocker, olmesartan medoxomil, attenuates lipid peroxidation in renal injury induced by subtotal nephrectomy.
Takahashi T; Konta T; Takasaki S; Ichikawa K; Takeishi Y; Kubota I
Clin Exp Nephrol; 2007 Sep; 11(3):202-208. PubMed ID: 17891346
[TBL] [Abstract][Full Text] [Related]
13. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
[TBL] [Abstract][Full Text] [Related]
14. A novel Sartan derivative with very low angiotensin II type 1 receptor affinity protects the kidney in type 2 diabetic rats.
Izuhara Y; Sada T; Yanagisawa H; Koike H; Ohtomo S; Dan T; Ito S; Nangaku M; van Ypersele de Strihou C; Miyata T
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1767-73. PubMed ID: 18658044
[TBL] [Abstract][Full Text] [Related]
15. Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats.
Ohashi N; Yamamoto T; Huang Y; Misaki T; Fukasawa H; Suzuki H; Togawa A; Suzuki S; Fujigaki Y; Nakagawa T; Nakamura Y; Suzuki F; Kitagawa M; Hishida A
Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1512-8. PubMed ID: 18784264
[TBL] [Abstract][Full Text] [Related]
16. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats.
de Resende MM; Mill JG
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137
[TBL] [Abstract][Full Text] [Related]
17. The angiotensin-II (AT-II) receptor blocker olmesartan reduces renal damage in animal models of hypertension and diabetes.
Pugsley MK
Proc West Pharmacol Soc; 2005; 48():35-8. PubMed ID: 16416656
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis.
Kinoshita Y; Kondo S; Urushihara M; Suga K; Matsuura S; Takamatsu M; Shimizu M; Nishiyama A; Kawachi H; Kagami S
Transl Res; 2011 Oct; 158(4):235-48. PubMed ID: 21925120
[TBL] [Abstract][Full Text] [Related]
19. Protection of renal impairment by angiotensin II type 1 receptor blocker in rats with post-infarction heart failure.
Wen Z; Cai M; Mai Z; Chen Y; Geng D; Wang J
Ren Fail; 2013; 35(5):766-75. PubMed ID: 23560762
[TBL] [Abstract][Full Text] [Related]
20. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
Song J; Meng L; Li S; Qu L; Li X
Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
